About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
On this page
short description
(Photo: © Getty Images/JurgaR)

Global Challenges Seminar on Vaccines: Accelerating Innovation and Access

In collaboration with Access to Medicine Foundation and WHO, WIPO held a Global Challenges seminar during which the Global Challenges Report "Vaccines: Accelerating Innovation and Access" was launched.

The seminar considered the challenge of reaching global immunization coverage through increasing access to current and future vaccines. It examined the role of biopharmaceutical and vaccine manufacturers, looked at how the vaccine market works, explored the role of product development partnerships in the field, and discussed the Access to Vaccines Index published by the Access to Medicine Foundation.

Meeting documents  | Practical Information | Video on Demand

Date: November 8, 2017

Location: Geneva, Switzerland

Global Challenges report: Vaccines Accelerating Innovation and Access

The report describes the innovation process for vaccines; limitations to vaccine access at various stages, including those related to intellectual property; as well as  approaches for addressing these impediments.

Opening remarks

Photo of Minelik Alemu GetahunMinelik Alemu Getahun

WIPO Deputy Director General, Global Issues Sector

Keynote

Photo of Seth Berkley Seth Berkley

CEO, Gavi - The Vaccine Alliance, Geneva, Switzerland

Respondent

Nora Dellepiane

Senior Regulatory Adviser to Serum Institute of India, Trélex, Switzerland

Closing remarks

Photo of Anatole KrattigerAnatole Krattiger

WIPO Director, Global Challenges Division

Session one

The Access to Vaccines Index:  How Vaccine Companies are Responding to Calls for Greater Immunization Coverage

This session included a discussion about how vaccine companies are responding to global calls to increase access to vaccines, drawing on findings from the Access to Vaccines Index, published by the Access to Medicine Foundation in March 2017. The Index is the first data-driven tool to map the landscape of vaccine company policy and behavior for making vaccines more accessible to communities that need them. By uncovering which practices are working, where and why, the Index is intended to help ensure global vaccine markets can serve all populations.

Speaker

Jayasree K. Iyer

Executive Director, Access to Medicine Foundation, Amsterdam, Netherlands

Session two

The WHO Perspective on Achieving Access to Vaccines:  Where are we now and What Needs to be Done?

During this session, Mr. Martin Friede, Coordinator of the Initiative for Vaccine Research at WHO, presented WHO’s viewpoint on achieving access to vaccines. He discussed the current context with respect to the vaccine landscape, some key issues at play, and steps that need to be taken to increase access including IP-related factors.

Speaker

Martin Howell Friede

Coordinator, Initiative for Vaccine Research (IVR), WHO, Geneva,  Switzerland

Session three

Moderated panel discussion on the launch of the Global Challenges Report Vaccines: Accelerating Innovation and Access followed

During this session, the new Global Challenges Report Vaccines: Accelerating Innovation and Access was launched.  Panelists representing Médecins Sans Frontières, the Coalition for Epidemic Preparedness Innovations, UNICEF, Industry and the Access to Medicine Foundation offered their perspectives and engaged the audience in a discussion around relevant issues brought to light in the report.

 


Moderated by Koenraad Debackere, Professor, University of Leuven, Belgium

Panelists

Hilde Stevens

Professor, Baillet Latour Chair in Translational Medicine (13h, ULB)

Rohit Malpani

Director of Policy & Analysis, Access Campaign, Medecins sans frontières (MSF), Geneva, Switzerland

Frederick Kristensen

Deputy CEO, Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway

Heather Deehan

Chief, Vaccine Centre, United Nations Children’s Fund (UNICEF) Supply Division, Copenhagen, Denmark

An Vermeersch

Vice President, Head, Global Health and Corporate affairs, GSK Vaccines, Brussels, Belgium

Jayasree K. Iyer

Executive Director, Access to Medicine Foundation, Amsterdam, Netherlands

 
 
    

Policy | Reference

Cooperation | Services

About IP

Inside WIPO

https://www3.wipo.int/contact/en/area.jsp?area=meetings https://www.wipo.int/pressroom/en/ https://www.wipo.int/tools/en/disclaim.html https://www.wipo.int/en/web/privacy-policy/ https://www.wipo.int/en/web/accessibility/ https://www.wipo.int/tools/en/sitemap.html https://www3.wipo.int/newsletters/en/ https://www.wipo.int/podcasts/en/ https://www.wipo.int/news/en/